Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Financing Activities (2017 - 2021)

Cogent Biosciences has reported Cash from Financing Activities over the past 5 years, most recently at $38.0 million for Q4 2021.

  • Quarterly results put Cash from Financing Activities at $38.0 million for Q4 2021, down 68.88% from a year ago — trailing twelve months through Dec 2021 was $38.0 million (down 83.64% YoY), and the annual figure for FY2025 was $878.2 million, up 309.53%.
  • Cash from Financing Activities for Q4 2021 was $38.0 million at Cogent Biosciences, up from $55000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for COGT hit a ceiling of $122.1 million in Q4 2020 and a floor of -$734000.0 in Q4 2017.
  • Median Cash from Financing Activities over the past 5 years was $85000.0 (2019), compared with a mean of $24.3 million.
  • Biggest five-year swings in Cash from Financing Activities: soared 563.64% in 2020 and later tumbled 216.44% in 2021.
  • Cogent Biosciences' Cash from Financing Activities stood at -$734000.0 in 2017, then skyrocketed by 153.81% to $395000.0 in 2018, then plummeted by 75.44% to $97000.0 in 2019, then soared by 125813.4% to $122.1 million in 2020, then crashed by 68.88% to $38.0 million in 2021.
  • The last three reported values for Cash from Financing Activities were $38.0 million (Q4 2021), $55000.0 (Q3 2021), and -$85000.0 (Q1 2021) per Business Quant data.